BioNTech's Sean Marett Explains Genentech Deal Rationale
Executive Summary
Chief operating officer of BioNTech Sean Marett talks to Mike Ward, global director of content for Informa Pharma Intelligence, about the German firm's recent co-development deal with Roche company Genentech.